NEOS SURGERY SL

Their core work

NEOS Surgery is a Spanish medical device SME specializing in implantable devices for spinal surgery, particularly solutions to prevent lumbar disc re-herniation. They develop products based on advanced materials — including shape-memory alloys and medical textiles — translating material science into functional surgical implants. Their work extends into biomaterial-based therapeutic devices for neurological conditions like multiple sclerosis, positioning them at the intersection of orthopedic surgery and regenerative medicine.

What they specialise in

How they've shifted over time

In their early H2020 period (2015-2018), NEOS focused on mechanical spinal implants using smart materials — the ACE project centered on shape-memory annulus closure devices. From 2017 onward, they expanded into neurological disease applications, participating in two MS-focused projects involving optogenetics and biomaterial therapies. Their most recent coordinated project (DISC care, 2021) returns to their core spinal device work but at a higher TRL, suggesting they are commercializing their original spine technology while maintaining a research pipeline in biomaterials for neurodegeneration.

NEOS is converging toward market-ready spinal devices while building longer-term biomaterial expertise for neurological applications — expect them to seek commercialization partners for spine products and research partners for MS therapies.

How they like to work

NEOS balances leadership and partnership equally — coordinating their core spinal device projects (ACE, DISC care) while joining as a participant in research-stage MS projects led by others. With 18 partners across 11 countries from just 4 projects, they build broad European consortia rather than relying on a small circle. This suggests they are open to new partnerships and comfortable working with diverse academic and industrial teams.

NEOS has collaborated with 18 unique partners across 11 countries, indicating a well-connected European network for a company of its size. Their partnerships span both industrial and academic organizations, reflecting their position between materials research and medical device commercialization.

What sets them apart

NEOS occupies a rare niche: an SME that both develops and coordinates EU projects for implantable spinal devices built on advanced materials science. Unlike large medtech firms, they bring startup agility and deep specialization in shape-memory and biomaterial implants. Their dual track — commercial spine devices plus research-stage neurological biomaterials — makes them an attractive partner for both near-market product development and longer-horizon biomedical research.

Highlights from their portfolio

• DISC care
  Their largest-funded project (EUR 1.93M) as coordinator, developing a commercialization-ready hernia blocking system — signals a product nearing market.
• ACE
  First coordinated project (EUR 1.9M) combining shape-memory materials with medical textiles for spinal implants — established their core technology platform.
• PMSMatTrain
  A 5-year MSCA training network for progressive MS treatment via biomaterials — shows NEOS contributing to talent development beyond their commercial focus.